[Neonatal drug-induced blepharoconjunctivitis. Difficulties of prevention and therapy of neonatal conjunctivitis].
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001762:Blepharitis / Q000139:chemically induced*; D003231:Conjunctivitis / Q000139:chemically induced*; D004338:Drug Combinations; D004342:Drug Hypersensitivity; D064420:Drug-Related Side Effects and Adverse Reactions; D005141:Eyelid Diseases / Q000139:chemically induced*; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D009583:Nitrofurazone / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D010656:Phenylephrine / Q000009:adverse effects; D012835:Silver Nitrate / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D009883:Ophthalmic Solutions; D010656:Phenylephrine; D012835:Silver Nitrate; D006854:Hydrocortisone; D009583:Nitrofurazone
Le blefarocongiuntiviti neonatali da farmaci. Osservazioni sugli inconvenienti della profilassi e terapia delle congiuntiviti neonatali.